Key result
Cardiac resynchronisation therapy recipients in Poland did not differ substantially in demographic and clinical characteristics compared to other European countries, with most indications aligning with guidelines.
Why the study?
Do indications and demographics of cardiac resynchronisation therapy recipients differ between Poland and other European countries?
Observational (n=11,088)
Yes
Do indications and demographics of cardiac resynchronisation therapy recipients differ between Poland and other European countries?
The demographic and clinical characteristics of CRT recipients in Poland are largely similar to those in other European countries, with most implantations adhering to ESC guidelines.
Supports guideline-concordant CRT use in Poland; leaves open regional outcome and access disparities.
Background: Multiple randomised clinical trials have proven that cardiac resynchronisation therapy (CRT) reduces morbidity and mortality in appropriately selected patients with congestive heart failure and is recommended for such patients as per the European Society of Cardiology guidelines. Aims: In this paper we compare the indications and demographics in cardiac resynchronisation recipients in Poland and other European countries. Methods: In 2015 and 2016 , physicians from 42 European countries participated in the second edition of the European Cardiac Resynchronisation Therapy Survey. For 14 months, 288 implanting centres gathered data regarding demography, indications, implanting methods, and guidance compatibility from 11,088 patients receiving CRT. Results: The survey revealed that a vast group of patients were eligible for CRT implantation (although some of them with relatively weak guidance recommendations) and showed essential variety in clinical practice when national data were benchmarked. Conclusions: The population of CRT recipients in Poland and other European countries did not differ in terms of demographic and clinical characteristics. In most cases, indications for CRT were in accordance with the guidelines; however some devices were implanted in patients beyond the guideline recommendations. For these procedures, the decision regarding CRT implantation relies mainly on the physicians’ experience.
No takes yet. Share an insight, caveat, or question.
Łasocha et al. (2018) conducted an observational in Congestive heart failure (n=11,088). Cardiac resynchronisation therapy (CRT) in Poland vs. Cardiac resynchronisation therapy (CRT) in other European countries was evaluated on Mean age (p=<0.00001). Cardiac resynchronisation therapy recipients in Poland did not differ substantially in demographic and clinical characteristics compared to other European countries, with most indications aligning with guidelines.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: